Trial Profile
Bendamustine +/- rituximab in patients with aggressive non-Hodgkin's lymphomas: a retrospective analysis
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 17 May 2014
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Rituximab
- Indications Diffuse large B cell lymphoma; Mantle-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 17 May 2014 New trial record